Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Chimerism

Stable mixed chimerism after T cell-depleted allogeneic hematopoietic stem cell transplantation using conditioning with low-dose total body irradiation and fludarabine

Abstract

Although reduced intensity conditioning (RIC) before allografting is associated with low treatment-related morbidity and mortality, graft-versus-host disease (GVHD) remains a significant complication of hematopoietic stem cell transplantation (HSCT). T cell depletion (TCD) has been successfully used in conventional allotransplantation to reduce the incidence of GVHD, but was associated with an increased rate of engraftment failure. In a small cohort of six patients at high risk of developing GVHD we have determined whether sustained engraftment could be achieved using reduced intensity conditioning and T cell depletion in combination. All patients engrafted and 5/6 developed high levels (ie 95%) of donor chimerism, even though mismatched related or matched unrelated donors were used. Only one patient developed acute GVHD, as he received donor lymphocyte infusions (DLI) for relapse. In summary, TCD might be a useful prophylactic tool in RIC allogeneic HSCT. Although TCD after RIC might be associated with high relapse rate, as 5/6 patients are not in remission, this combined strategy might be appropriate for patients with less aggressive malignant or non-malignant diseases in which high transplant-related morbidity and mortality is not acceptable.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Kolb HJ, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia Blood 1995 86: 2041 250

    CAS  PubMed  Google Scholar 

  2. Childs R, Chernoff A, Contentin N et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation New Engl J Med 2000 343: 750 758

    Article  CAS  PubMed  Google Scholar 

  3. Horwitz ME, Barrett AJ, Brown MR et al. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft New Engl J Med 2001 344: 881 888

    Article  CAS  PubMed  Google Scholar 

  4. Horwitz EM, Prockop DJ, Gordon PL et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta Blood 2001 97: 1227 1231

    Article  CAS  PubMed  Google Scholar 

  5. Gahrton G, Tura S, Ljungman P et al. Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow Transplantation New Engl J Med 1991 325: 1267 1273

    Article  CAS  PubMed  Google Scholar 

  6. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor Blood 1995 85: 1655 1658

    CAS  PubMed  Google Scholar 

  7. Storb R, Yu C, Wagner JL et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation Blood 1997 89: 3048 3054

    CAS  PubMed  Google Scholar 

  8. Fuchimoto Y, Huang CA, Yamada K et al. Mixed chimerism and tolerance without whole body irradiation in a large animal model J Clin Invest 2000 105: 1779 1789

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Sykes M, Preffer F, McAfee S et al. Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation Lancet 1999 353: 1755 1759

    Article  CAS  PubMed  Google Scholar 

  10. Storb R, McSweeney PA, Sandmaier BM et al. Allogeneic hematopoietic stem cell transplantation: from the nuclear age into the twenty-first century Transplant Proc 2000 32: 2548 2549

    Article  CAS  PubMed  Google Scholar 

  11. Urbano-Ispizua A, Rozman C, Martinez C et al. Rapid engraftment without significant graft-versus-host disease after allogeneic transplantation of CD34+ selected cells from peripheral blood Blood 1997 89: 3967 3973

    CAS  PubMed  Google Scholar 

  12. Maraninchi D, Gluckman E, Blaise D et al. Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias Lancet 1987 2: 175 178

    Article  CAS  PubMed  Google Scholar 

  13. Martin PJ, Hansen JA, Torok-Storb B et al. Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants Bone Marrow Transplant 1988 3: 445 456

    CAS  PubMed  Google Scholar 

  14. Giralt S, Khouri I, Champlin R . Non myeloablative ‘mini transplants’ Cancer Treat Res 1999 101: 97 108

    Article  CAS  PubMed  Google Scholar 

  15. Goerner M, Wandt H, Schafer-Eckart K et al. The use of CD34+-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complications J Hematother Stem Cell Res 1999 8: 387 391

    Article  CAS  PubMed  Google Scholar 

  16. Martinez C, Urbano-Ispizua A, Rozman C et al. Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts Exp Hematol 1999 27: 561 568

    Article  CAS  PubMed  Google Scholar 

  17. Craddock C, Bardy P, Kreiter S et al. Short report: engraftment of T-cell-depleted allogeneic haematopoietic stem cells using a reduced intensity conditioning regimen Br J Haematol 2000 111: 797 800

    CAS  PubMed  Google Scholar 

  18. Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases Blood 1998 91: 756 763

    CAS  PubMed  Google Scholar 

  19. Flowers CR, Sandmaier BM, Maloney DG et al. Regimen related toxicities associated with non-myeloablative conditioning and postgrafting cyclosporine and mycophenolate Blood 2000 96: 521a (Abstr.)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Görner, M., Kordelas, L., Thalheimer, M. et al. Stable mixed chimerism after T cell-depleted allogeneic hematopoietic stem cell transplantation using conditioning with low-dose total body irradiation and fludarabine. Bone Marrow Transplant 29, 621–624 (2002). https://doi.org/10.1038/sj.bmt.1703427

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703427

Keywords

This article is cited by

Search

Quick links